Thyme Thymus vulgaris L.
Also called: thyme herb, Origanum thymus Kuntze (synonym)
Thyme (Thymus vulgaris) is a subshrub whose dried herb is used as a culinary spice and in cough preparations. The composition of its essential oil differs between chemotypes, such as thymol, linalool and geraniol types.
- Category
- Botanical
- Part used
- Herb (aerial parts); the EU monograph also covers Thymus zygis
- Strongest evidence
- C Limited
- Native range
- Native to southwest Europe and southeast Italy (POWO: "SW. Europe, SE. Italy")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. This entry cites 3 RCTs of thyme (Thymus vulgaris) alone: source [4] (oral syrup of thyme powder, 60 children with asthma), source [9] (oral leaves 500 mg twice daily, 106 students) and source [10] (drops of 2% thyme essential oil versus ibuprofen or placebo, 84 students with dysmenorrhea). [4]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CLungs and airways2 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Acute bronchitis with productive cough (thyme–ivy combination) | C | A double-blind RCT in 361 adults found a thyme–ivy syrup (5.4 ml three times daily, 11 days) cut daytime coughing fits by 68.7% versus 47.6% with placebo; thyme was not tested alone. [3] |
| Cough in children with asthma flare-ups | C | In 60 children aged 5–12, thyme syrup (20 mg/kg every 8 hours for a week) added to usual care reduced activity-induced cough versus placebo; wheezing and breathlessness did not differ. [4] |
Main constituents: Essential-oil constituents thymol and carvacrol; flavonoids [1]; Chemotypes cultivated in southern France: thymol (41.0% thymol), geraniol (26.4% geraniol), linalool (72.5% linalool) and 4-thujanol/terpinen-4-ol [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Studied in trials: thyme–ivy fluid-extract syrup 5.4 ml three times daily for 11 days (adults with acute bronchitis). [3]
- Studied in trials: thyme powder syrup 20 mg/kg every 8 hours for one week (children 5–12 with asthma exacerbation). [4]
- Stated in a regulatory monograph (EU, EMA HMPC, 2013), traditional use in productive cough with colds, from age 12: herbal tea of 1–2 g in 150 ml boiling water 3–4 times daily, or other listed extracts. [5]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingEU monograph (2013): safety during pregnancy and lactation has not been established; use is not recommended. No fertility data.
1 statement in the profile.
Details and sources - Interactions with medicinesNone reported
Medicines in general: EU monograph (EMA HMPC, 2013), section 4.5: none reported.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographs2 statements
EU (EMA HMPC monograph, 12 November 2013), traditional use in productive cough with colds, adolescents and adults: e.g.
Details and sources
- Gastric disorders may occur (frequency not known); hypersensitivity to thyme or other Lamiaceae plants is a contraindication (EU monograph). [5]
- Safety during pregnancy and lactation has not been established; the EU monograph does not recommend use then. [5]
- The EU monograph advises seeing a doctor if shortness of breath, fever or purulent sputum occurs. [5]
Identity, quality and standardization
Regulatory status
- US: No NDI notification naming thyme (Thymus vulgaris) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [6]
- EU: EMA's HMPC monograph (2013) recognizes traditional use of thyme preparations in productive cough associated with colds. [5]
- US food use: 21 CFR 182.10 lists thyme (Thymus vulgaris L.) among spices and natural seasonings generally recognized as safe for their intended use. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming thyme (Thymus vulgaris) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
- Food use: 21 CFR 182.10 (spices and other natural seasonings and flavorings) lists thyme (Thymus vulgaris L.) as generally recognized as safe for its intended use. [P3]
- Food use: 21 CFR 182.20 (essential oils, oleoresins and natural extractives) lists thyme (Thymus vulgaris L.) as generally recognized as safe for its intended use. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of thyme was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
- NTP technical reports list checked: no report on thyme. [P6]
- EU monograph: adequate tests on reproductive toxicity, genotoxicity and carcinogenicity have not been performed. [P7]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Medicines in general: EU monograph (EMA HMPC, 2013), section 4.5: none reported. [P7]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of each dietary-ingredient lot (at least one appropriate test or examination) — Required for any component that is a dietary ingredient under 21 CFR 111.75(a)(1)(i), unless FDA grants a petition exemption. [P8]
- Compliance with the Ph. Eur. monograph for thyme (ref. 04/2009:0865) — The EU herbal monograph defines the herbal substance by this Ph. Eur. monograph. [P7]
- Essential-oil profile by GC-MS/GC-FID (chemotype) — Thymol, geraniol, linalool and 4-thujanol/terpinen-4-ol chemotypes of the same species have very different oil compositions. [P9]
Supply and conservation
- IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P10]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU (EMA HMPC monograph, 12 November 2013), traditional use in productive cough with colds, adolescents and adults: e.g. herbal tea of 1–2 g in 150 ml boiling water 3–4 times daily; liquid extract (DER 1:1) 1–2 ml 3–4 times daily; dry extract (DER 6–10:1) 75–200 mg 3 times daily. [P7]
- EU (same monograph): two preparations may be used from age 4; the others are not recommended under 12. See a doctor if symptoms last more than 1 week. [P7]
Pregnancy and breastfeeding
- EU monograph (2013): safety during pregnancy and lactation has not been established; use is not recommended. No fertility data. [P7]
Sources for this profile
- Hammoudi Halat D, et al. A focused insight into thyme: biological, chemical, and therapeutic properties of an indigenous Mediterranean herb. Nutrients 2022;14(10):2104 (PMID 35631245), 2022-05-18. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- eCFR. 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- IARC Monographs. Agents Classified by the IARC Monographs, Volumes 1–142 (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list of 2-year studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- European Medicines Agency (HMPC). Community herbal monograph on Thymus vulgaris L. and Thymus zygis L., herba. EMA/HMPC/342332/2013 (12 November 2013), 2013-11-12. ema.europa.eu
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- Schmidt E, et al. Chemical composition, olfactory analysis and antibacterial activity of Thymus vulgaris chemotypes geraniol, 4-thujanol/terpinen-4-ol, thymol and linalool cultivated in southern France. Nat Prod Commun 2012;7(8):1095-8 (PMID 22978238), 2012-08. pubmed.ncbi.nlm.nih.gov
- GBIF species API: IUCN Red List category for Thymus vulgaris, 2026-10-29. api.gbif.org
Sources
- Hammoudi Halat D, et al. A focused insight into thyme: biological, chemical, and therapeutic properties of an indigenous Mediterranean herb. Nutrients 2022;14(10):2104 (PMID 35631245), 2022-05-18. pubmed.ncbi.nlm.nih.gov
- Schmidt E, et al. Chemical composition, olfactory analysis and antibacterial activity of Thymus vulgaris chemotypes geraniol, 4-thujanol/terpinen-4-ol, thymol and linalool cultivated in southern France. Nat Prod Commun 2012;7(8):1095-8 (PMID 22978238), 2012-08. pubmed.ncbi.nlm.nih.gov
- Kemmerich B, et al. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung 2006;56(9):652-60 (PMID 17063641), 2006. pubmed.ncbi.nlm.nih.gov
- Eskandarpour E, et al. Thymus vulgaris ameliorates cough in children with asthma exacerbation: a randomized, triple-blind, placebo-controlled clinical trial. Allergol Immunopathol (Madr) 2024;52(1):9-15 (PMID 38186189), 2024. pubmed.ncbi.nlm.nih.gov
- European Medicines Agency (HMPC). Community herbal monograph on Thymus vulgaris L. and Thymus zygis L., herba. EMA/HMPC/342332/2013 (12 November 2013), 2013-11-12. ema.europa.eu
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Thymus vulgaris L. (accessed 2026-10-29). powo.science.kew.org
- Alqudah A, et al. Effects of orally administered Thymus vulgaris leaves on memory, anxiety, depression, and sleep quality in university students: a randomized controlled trial. Eur Rev Med Pharmacol Sci 2023;27(22):10806-10814 (PMID 38039009), 2023-11. pubmed.ncbi.nlm.nih.gov
- Salmalian H, et al. Comparative effect of Thymus vulgaris and ibuprofen on primary dysmenorrhea: a triple-blind clinical study. Caspian J Intern Med 2014;5(2):82-8 (PMID 24778782), 2014-04. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.